David A. Siegel Amgen Inc Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Amgen Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 716,900 shares of AMGN stock, worth $229 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

716,900

Previous 349,700 105.0%

Holding current value

$229 Million

Previous $99.4 Million 125.29%

% of portfolio

0.51%

Previous 0.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $96.5 Million - $117 Million	367,200 Added 105.0%	716,900 $224 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $218 Million - $263 Million	-809,000 Reduced 69.82%	349,700 $99.4 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $76 Million - $85.8 Million	-297,400 Reduced 20.42%	1,158,700 $334 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $32.1 Million - $39.9 Million	-146,800 Reduced 9.16%	1,456,100 $391 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $15 Million - $17.7 Million	-69,900 Reduced 4.18%	1,602,900 $356 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $30.6 Million - $37.3 Million	135,400 Added 8.81%	1,672,800 $404 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $33.5 Million - $42.5 Million	-146,100 Reduced 8.68%	1,537,400 $404 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $4.89 Million - $5.52 Million	21,800 Added 1.31%	1,683,500 $379 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $15.9 Million - $17.7 Million	-68,800 Reduced 3.98%	1,661,700 $404 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $17.1 Million - $18.9 Million	-77,900 Reduced 4.31%	1,730,500 $418 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $8.75 Million - $10 Million	-44,000 Reduced 2.38%	1,808,400 $407 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $121 Million - $142 Million	572,000 Added 44.67%	1,852,400 $394 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $289 Million - $321 Million	1,238,900 Added 2985.3%	1,280,400 $312 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $7.5 Million - $8.74 Million	33,800 Added 438.96%	41,500 $10.3 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $580,980 - $691,843	2,685 Added 53.54%	7,700 $1.77 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $56.9 Million - $63.3 Million	-242,636 Reduced 97.97%	5,015 $1.28 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $3.86 Million - $4.73 Million	19,500 Added 8.55%	247,651 $58.4 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $56.1 Million - $74.5 Million	-308,045 Reduced 57.45%	228,151 $46.3 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $90.3 Million - $116 Million	-477,200 Reduced 47.09%	536,196 $129 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $287 Million - $344 Million	-1,651,200 Reduced 61.97%	1,013,396 $196 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $69.2 Million - $81.2 Million	415,300 Added 18.46%	2,664,596 $491 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $32.6 Million - $36.7 Million	180,000 Added 8.7%	2,249,296 $427 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $56.3 Million - $65.7 Million	315,600 Added 18.0%	2,069,296 $403 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $33.7 Million - $38 Million	182,100 Added 11.59%	1,753,696 $364 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $130 Million - $145 Million	780,100 Added 98.56%	1,571,596 $290 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $255 Million - $299 Million	-1,507,700 Reduced 65.58%	791,496 $135 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $22 Million - $24.6 Million	130,500 Added 6.02%	2,299,196 $400 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $363 Million - $414 Million	2,168,696	2,168,696 $404 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account